threonine has been researched along with Ovarian Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eroglu, EC; Kucukgoz Gulec, U; Paydas, S; Vardar, MA | 1 |
| Chao, A; Chi, LM; Jung, SM; Lee, YS; Lin, CY; Tsai, CL; Tsai, CN | 1 |
| Celo, A; Kasberg, WC; Liang, Z; Quispe, K; Stack, MS; Yang, J | 1 |
| Ding, K; Jeyabal, PV; Shi, ZZ; Song, R; Wang, G; Weiskoff, AM; Xu, D | 1 |
| Cybulska, P; Eccles, LA; Jelinic, P; Levine, DA; Powell, SN; Tseng, J; Wielgos, M | 1 |
| Ahmed, AA; Bast, RC; Claret, FX; He, G; Hung, MC; Le, XF; Mao, W; Siddik, ZH; Xia, W | 1 |
| Agarwal, R; D'Souza, T; Morin, PJ | 1 |
| Chun, T; Lee, JH; Lee, KW; Lee, SH; Park, K; Rho, SB | 1 |
| Adachi, S; Itamochi, H; Sudo, T; Takahashi, T; Tamamori-Adachi, M; Ueno, NT; Yamasaki, F | 1 |
| Liang, X; Reed, E; Yu, JJ | 1 |
10 other study(ies) available for threonine and Ovarian Neoplasms
| Article | Year |
|---|---|
GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor.
Topics: Benzoic Acid; Biomarkers; Creatinine; Female; Gas Chromatography-Mass Spectrometry; Glutathione; Glycine; Humans; Metabolomics; Ovarian Neoplasms; Pyrrolidonecarboxylic Acid; RNA, Transfer; Serine; Threonine | 2022 |
Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma.
Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Movement; Disease Progression; Female; Glycogen Synthase Kinase 3 beta; Humans; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Models, Biological; Mutation; Neoplasm Staging; Ovarian Neoplasms; Phosphorylation; Protein Binding; Protein Stability; Proto-Oncogene Protein c-ets-1; Serine; Substrate Specificity; Threonine | 2021 |
Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.
Topics: Amino Acid Substitution; Animals; Cell Adhesion; Cell Aggregation; Cell Line, Tumor; Cell Movement; Female; Green Fluorescent Proteins; Humans; Matrix Metalloproteinase 14; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Neoplasm Proteins; Ovarian Neoplasms; Peritoneum; Phosphorylation; Point Mutation; Protein Interaction Domains and Motifs; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Threonine; Tissue Culture Techniques | 2017 |
Obg-like ATPase 1 regulates global protein serine/threonine phosphorylation in cancer cells by suppressing the GSK3β-inhibitor 2-PP1 positive feedback loop.
Topics: Adenosine Triphosphatases; Animals; Blotting, Western; Colorectal Neoplasms; Feedback, Physiological; Female; Glycogen Synthase Kinase 3 beta; GTP-Binding Proteins; Humans; Immunoenzyme Techniques; Mice; Mice, SCID; Ovarian Neoplasms; Phosphoproteins; Phosphorylation; Protein Phosphatase 1; Proteins; Serine; Signal Transduction; Threonine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.
Topics: Breast Neoplasms; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Repair; Female; Humans; Immunoblotting; Immunoprecipitation; Neoplasm Proteins; Nuclear Proteins; Ovarian Neoplasms; Phosphorylation; Real-Time Polymerase Chain Reaction; Repressor Proteins; Threonine | 2017 |
The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Confounding Factors, Epidemiologic; Cyclin-Dependent Kinase Inhibitor p27; Dasatinib; Drug Synergism; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Genes, bcl-1; Humans; Immunoblotting; Immunoprecipitation; In Situ Nick-End Labeling; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Research Design; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Serine; src-Family Kinases; Thiazoles; Threonine; Tyrosine; Xenograft Model Antitumor Assays | 2011 |
Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells.
Topics: Binding Sites; Calcium; Cell Line; Cell Line, Tumor; Claudin-3; Claudin-4; Cyclic AMP-Dependent Protein Kinases; Electric Impedance; Electrophoresis, Polyacrylamide Gel; Electrophysiology; Enzyme Inhibitors; Female; Glutathione Transferase; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Membrane Proteins; Microscopy, Fluorescence; Models, Genetic; Mutation; Ovarian Neoplasms; Permeability; Phosphorylation; Protein Structure, Tertiary; Recombinant Fusion Proteins; Recombinant Proteins; Threonine; Tight Junctions; Time Factors; Transfection | 2005 |
The identification of apoptosis-related residues in human thymosin beta-10 by mutational analysis and computational modeling.
Topics: Actins; Apoptosis; Computational Biology; DNA Mutational Analysis; Female; Humans; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Ovarian Neoplasms; Threonine; Thymosin; Tumor Cells, Cultured | 2005 |
Cyclin A-associated kinase activity is needed for paclitaxel sensitivity.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; CDC2 Protein Kinase; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Threonine; Transfection; Tumor Cells, Cultured | 2005 |
Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Checkpoint Kinase 2; Cisplatin; Enzyme Inhibitors; Female; Humans; Immunoprecipitation; Okadaic Acid; Ovarian Neoplasms; Phosphoprotein Phosphatases; Phosphorylation; Protein Binding; Protein Phosphatase 2; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Threonine; Time Factors; Tumor Suppressor Protein p53 | 2006 |